Martin Termathe

Statistics

Publications

Citations

498

H-Index

Active since

2012

Affiliations

Max Planck Institute for Molecular Biomedicine(Current)

TU Dortmund University

University Hospital Cologne

Chemical Genomics Centre

University of Cologne

Martin Termathe is an author at Max Planck Institute for Molecular Biomedicine specializing in life sciences, molecular biology, and structural biology.

ORCID

Publications per year

2012–2020

Publications

Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer

Francesca Rapino, Lars Tharun, Zhaoli Zhou et al. · The Journal of Experimental Medicine · 2016 · 181 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach

Julian Engel, André Richters, Matthäus Getlik et al. · Journal of Medicinal Chemistry · 2015 · 112 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma

Johannes Brägelmann, Marcel A. Dammert, Felix Dietlein et al. · Cell Reports · 2017 · 55 citations · Full text

Medicine, Cancer Biology, Oncology +17

Glutaredoxin GRXS17 Associates with the Cytosolic Iron-Sulfur Cluster Assembly Pathway

Sabrina Iñigo, Astrid Nagels Durand, Andrés Ritter et al. · PLANT PHYSIOLOGY · 2016 · 47 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Fluorophore Labeled Kinase Detects Ligands That Bind within the MAPK Insert of p38α Kinase

Matthäus Getlik, Jeffrey R. Simard, Martin Termathe et al. · PLoS ONE · 2012 · 36 citations · Full text

Life Sciences, Chemical Biology, Molecular Biology +16

1–5 of 7